Cargando…
Alum impairs tolerogenic properties induced by allergoid‐mannan conjugates inhibiting mTOR and metabolic reprogramming in human DCs
BACKGROUND: Polymerized allergoids conjugated to mannan (PM) are suitable vaccines for allergen‐specific immunotherapy (AIT). Alum remains the most widely used adjuvant in AIT, but its way of action is not completely elucidated. The better understanding of the mechanisms underlying alum adjuvanticit...
Autores principales: | Benito‐Villalvilla, Cristina, Soria, Irene, Pérez‐Diego, Mario, Fernández‐Caldas, Enrique, Subiza, José Luis, Palomares, Oscar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079174/ https://www.ncbi.nlm.nih.gov/pubmed/31494959 http://dx.doi.org/10.1111/all.14036 |
Ejemplares similares
-
Novel vaccines targeting dendritic cells by coupling allergoids to mannan
por: Benito-Villalvilla, Cristina, et al.
Publicado: (2018) -
Structural studies of novel glycoconjugates from polymerized allergens (allergoids) and mannans as allergy vaccines
por: Manzano, Ana I., et al.
Publicado: (2015) -
Oral myeloid cells uptake allergoids coupled to mannan driving Th1/Treg responses upon sublingual delivery in mice
por: Soria, I., et al.
Publicado: (2018) -
Alum‐adjuvanted allergoids induce functional IgE‐blocking antibodies
por: Reithofer, M., et al.
Publicado: (2018) -
First‐in‐human phase 2 trial with mite allergoids coupled to mannan in subcutaneous and sublingual immunotherapy
por: Nieto, Antonio, et al.
Publicado: (2022)